Correlation Between OncoVista Innovative and Neurobiological Technologies
Can any of the company-specific risk be diversified away by investing in both OncoVista Innovative and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoVista Innovative and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoVista Innovative Therapies and Neurobiological Technologies, you can compare the effects of market volatilities on OncoVista Innovative and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoVista Innovative with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoVista Innovative and Neurobiological Technologies.
Diversification Opportunities for OncoVista Innovative and Neurobiological Technologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between OncoVista and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OncoVista Innovative Therapies and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and OncoVista Innovative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoVista Innovative Therapies are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of OncoVista Innovative i.e., OncoVista Innovative and Neurobiological Technologies go up and down completely randomly.
Pair Corralation between OncoVista Innovative and Neurobiological Technologies
If you would invest 0.01 in OncoVista Innovative Therapies on November 2, 2024 and sell it today you would earn a total of 0.01 from holding OncoVista Innovative Therapies or generate 100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 20.52% |
| Values | Daily Returns |
OncoVista Innovative Therapies vs. Neurobiological Technologies
Performance |
| Timeline |
| OncoVista Innovative |
| Neurobiological Technologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
OncoVista Innovative and Neurobiological Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoVista Innovative and Neurobiological Technologies
The main advantage of trading using opposite OncoVista Innovative and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoVista Innovative position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.| OncoVista Innovative vs. Cyclacel Pharmaceuticals | OncoVista Innovative vs. Amylyx Pharmaceuticals | OncoVista Innovative vs. Axsome Therapeutics | OncoVista Innovative vs. Exelixis |
| Neurobiological Technologies vs. Pharming Group NV | Neurobiological Technologies vs. Kane Biotech | Neurobiological Technologies vs. Health Sciences Gr | Neurobiological Technologies vs. MedMira |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |